EA
PLXP

Emerald Acquisition’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Emerald Acquisition’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.59M Buy
13,718
+2,942
+27% +$287K ﹤0.01% 1873
2016
Q2 		$854K Buy
+10,776
New +$934K ﹤0.01% 2250

Other funds holding PLXP

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSVM
Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
TCM
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Emerald Acquisition's PLXP Position: Q3 2016 in Review

Emerald Acquisition increased its PLx Pharma Inc. Common Stock (PLXP) stake by 27% in Q3 2016, buying an estimated $287K and bringing the position to 13,718 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1873.

Emerald Acquisition first reported a position in PLXP in Q2 2016 and has held it in 2 quarters since. 32 funds tracked by Wall St. Rank hold PLXP as of Q3 2016.

  • Emerald Acquisition held 13,718 shares of PLx Pharma Inc. Common Stock worth $1.59M as of Q3 2016.
  • Emerald Acquisition bought 2,942 PLx Pharma Inc. Common Stock shares in Q3 2016, an estimated $287K.
  • PLx Pharma Inc. Common Stock made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1873 holding.
  • Emerald Acquisition first reported a position in PLx Pharma Inc. Common Stock in Q2 2016 and has held it in 2 quarters since.
  • 32 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.